Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005104 · ClinicalTrials.gov registry record · NA
Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT00005104 is a NA study that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 99 participants.
The verdict
NCT00005104, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.
Interventions
- DRUG metformin
- DRUG clomiphene citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2000-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005104
The ClinicalTrials.gov registry entry for NCT00005104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which metformin is the first listed.
NCT00005104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005104 about?
NCT00005104 is a clinical study titled "Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome". OBJECTIVES: I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.
What is the current status of trial NCT00005104?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2000-01.
What interventions are being tested in trial NCT00005104?
The interventions under investigation include: metformin (DRUG), clomiphene citrate (DRUG).
Who is sponsoring clinical trial NCT00005104?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.